Multi-billion dollar SymphonyAI Group unites clinical AI leader with patient engagement pioneer to form GW RhythmX, serving 150 health systems nationwide and combining medical superintelligence with proven digital engagement across the care continuum.
Medical Superintelligence Meets Patient Engagement at Enterprise Scale
Deepthi Bathina – Founder and CEO of RhythmX AI
RhythmX AI and Get Well, both part of the SymphonyAI Group portfolio, have merged to form GW RhythmX, a single company positioned to transform how health systems deliver care, engage patients, and optimize financial performance. The combined entity unites two distinct but complementary platforms: RhythmX AI’s AI-native precision care platform for clinicians and Get Well’s market-leading digital patient engagement infrastructure, creating what executives describe as healthcare’s first fully integrated intelligence-driven care delivery system.
The merger brings together RhythmX AI’s clinical AI that delivers hyper-personalized treatment recommendations directly into physician workflows with Get Well’s proven patient engagement solutions serving more than 10 million annual patient interactions. Together, GW RhythmX now reaches more than 150 health systems, 62 Veterans Affairs medical centers, and has impacted the lives of more than 85 million patients—including 1 million U.S. military veterans.
“With our companies coming together as one, we have the opportunity to forever change the way medicine is practiced. By orchestrating all of healthcare’s data into one platform of actionable intelligence, we’re helping clinicians focus on what matters most, giving patients a more connected experience, and enabling health systems to achieve new levels of operational and financial performance.” — Deepthi Bathina, CEO of the combined company
Deepthi Bathina, Founder and CEO of RhythmX AI, will lead GW RhythmX as CEO. Michael O’Neil, Get Well’s Founder and CEO, transitions to Vice Chairman. “With our companies coming together as one, we have the opportunity to forever change the way medicine is practiced,” Bathina said in the announcement. “By orchestrating all of healthcare’s data into one platform of actionable intelligence, we’re helping clinicians focus on what matters most, giving patients a more connected experience, and enabling health systems to achieve new levels of operational and financial performance.”
RhythmX AI: Clinical Intelligence That Combines Quality with Revenue Integrity
RhythmX AI’s Precision Care Platform addresses physician cognitive overload by unifying fragmented healthcare data into actionable clinical intelligence. According to the company, the platform integrates more than 10 data sources—including clinical, payer, financial, and social determinants of health data alongside EHR information, health system policies, and clinical guidelines—into a single workflow that surfaces next-best actions for each patient encounter.
The clinical impact is already measurable. According to RhythmX AI, the platform has delivered more than 300,000 uniquely personalized treatment recommendations, validated through more than 25,000 clinical reviews by practicing physicians and specialists. These recommendations span the full care spectrum: predicting disease progression, identifying undiagnosed conditions, orchestrating appropriate specialist referrals, and optimizing documentation and coding at the point of care.
What the company describes as “medical superintelligence with medical economics” represents a strategic differentiation from clinical AI tools focused solely on decision support. The platform simultaneously addresses clinical quality and financial performance by ensuring proper level-of-service capture and documentation accuracy. According to RhythmX AI, the platform’s medical economics engine has been validated by certified coders and demonstrates potential for $57 million in incremental annual revenue for just 200 primary care physicians.
The platform integrates with any health system EHR and is built for rapid enterprise deployment, currently live in health system clinics with partnerships including Presbyterian Healthcare Services and Sentara Health.
Get Well: Proven Patient Engagement Across the Care Continuum
Get Well brings more than two decades of patient engagement expertise to the merger, with digital solutions deployed across inpatient, outpatient, and post-acute care settings. The company’s platform enables patients to access personalized education, communicate with care teams, and actively participate in their care journey through smart room technology, mobile applications, and digital whiteboards.
According to Get Well, customers have captured significant new revenue, reduced hospital readmissions by over 65%, and achieved very high levels of patient satisfaction. The company’s client roster includes some of the nation’s largest health systems: Kaiser Permanente, Ascension, Adventist Healthcare, Stanford Medicine, and the U.S. Department of Veterans Affairs, with solutions deployed in more than 1,000 healthcare organizations. Get Well’s solutions have been recognized by KLAS Research, Fierce Healthcare, and AVIA Marketplace.
Get Well’s infrastructure provides the patient-facing layer that can now connect directly to RhythmX AI’s clinical intelligence, extending physician-driven care plans into patients’ hands across multiple touchpoints. This integration enables what GW RhythmX describes as precision engagement—patient interactions informed by the same AI-driven insights that guide clinician decision-making.
Dual Platform Strategy in a Consolidating Market
The merger positions GW RhythmX distinctly in a healthcare technology landscape seeing significant consolidation. Earlier this year, TigerConnect acquired eVideon to combine clinical communications with smart room patient engagement technology. The RhythmX AI-Get Well merger follows similar consolidation logic but operates across different layers of the technology stack.
On the clinical AI side, RhythmX AI competes with ambient AI documentation platforms, EHR-embedded clinical decision support tools, and specialized AI applications for specific conditions or specialties. The platform’s differentiation centers on comprehensive data integration across clinical, financial, and social determinants paired with validated revenue optimization—positioning it as a dual clinical quality and financial performance tool rather than purely clinical workflow automation.
On the patient engagement side, Get Well faces competition from established platforms like Oneview Healthcare’s Care Experience Platform and similar smart room and digital engagement solutions. Get Well’s scale—serving major health systems and the VA healthcare system—and its two-decade operational track record differentiate it in a market where newer entrants are still proving long-term reliability.
GW RhythmX’s strategic bet is that winning health system contracts requires addressing both sides of the equation simultaneously: relieving clinician burden while improving patient experience, all while demonstrating measurable financial return. This integrated approach contrasts with point solutions that address only clinical workflow or only patient engagement, requiring health systems to manage multiple vendor relationships and integration complexities.
Multi-Billion Dollar Backing and Proven AI Infrastructure
The merger leverages SymphonyAI Group’s substantial resources and AI expertise. Dr. Romesh Wadhwani, SymphonyAI Group Chairman, has committed more than $1 billion in R&D investment to the healthcare AI portfolio. GW RhythmX draws on longitudinal data related to 300 million patients, 4.4 billion total annual claims, and 1.8 million healthcare professionals at more than 3,000 facilities globally.
“For a long time I’ve seen the power of AI to reshape industries. With RhythmX AI and Get Well together, we now have the team, technology, and scale to do the same for healthcare uniting AI with our deep knowledge of healthcare and patient needs, rapid innovation, and financial strength to help health systems thrive in the new era of patient-centric, AI-powered precision care.” — Dr. Romesh Wadhwani, Chairman of SymphonyAI Group
“For a long time I’ve seen the power of AI to reshape industries,” Wadhwani said. “With RhythmX AI and Get Well together, we now have the team, technology, and scale to do the same for healthcare uniting AI with our deep knowledge of healthcare and patient needs, rapid innovation, and financial strength to help health systems thrive in the new era of patient-centric, AI-powered precision care.”
SymphonyAI Group’s portfolio includes SymphonyAI (enterprise AI across retail, financial services, and other industries) and ConcertAI (real-world data and AI for life sciences). The healthcare companies benefit from shared AI infrastructure, including the Eureka AI platform that powers solutions for thousands of global customers.
Leadership Transition and Strategic Vision
Bathina brings more than two decades of experience at the intersection of healthcare, technology, and AI innovation. She previously held senior executive leadership roles at Humana, Nuance Communications, and Wolters Kluwer Health, where she oversaw business growth and innovation impacting 16 million members across Medicare, Medicaid, and commercial markets. She has also led global operations scaling AI-powered solutions used by hundreds of thousands of clinicians in over 170 countries.
“This is an exciting day for SymphonyAI Group, our two companies and the industry. The opportunity to leverage decades of enterprise AI at SymphonyAI Group with patient engagement leadership at Get Well, fused together by RhythmX AI’s advanced AI will bring a better future faster, for clinicians and the patients they care for.” — Michael O’Neil, Vice Chairman of GW RhythmX
O’Neil’s transition to Vice Chairman reflects standard post-merger governance while maintaining continuity through his advisory role. “This is an exciting day for SymphonyAI Group, our two companies and the industry,” O’Neil said. “The opportunity to leverage decades of enterprise AI at SymphonyAI Group with patient engagement leadership at Get Well, fused together by RhythmX AI’s advanced AI will bring a better future faster, for clinicians and the patients they care for.”
GW RhythmX’s value proposition centers on a simple premise: health systems need solutions that simultaneously address clinician burden, patient experience, and financial sustainability. By uniting clinical intelligence with patient engagement infrastructure, the merged entity aims to deliver measurable improvements across all three dimensions—a claim that will be tested as the integration proceeds and customers evaluate the combined platform’s real-world performance.
– This original article was created with AI support.
